Agriculture appropriations
This article was originally published in The Gray Sheet
Executive Summary
No funds may be used to "develop or establish" user-fee programs, according to Agriculture appropriations conference report language passed by the House Nov. 14 and the Senate Nov. 15. The measure authorizes $179.5 mil. for the FDA device center, up 8.7% from fiscal year 2001. It also provides a $15 mil. increase for bovine spongiform encephalopathy prevention and enforcement, a $10 mil. increase for adverse event monitoring and reporting, a $10 mil. increase for human subject protection and a $10.3 mil. increase for inspections and import monitoring...
You may also be interested in...
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
Dr Reddy’s Knocked Back On Rituximab In US
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.
Sandoz And Samsung Celebrate Stelara Rival’s EU Approval
Sandoz and Samsung Bioepis have received final European Commission approval for their partnered Pyzchiva biosimilar rival to Stelara. But with European competition on ustekinumab due to kick off in just a matter of months, further applicants are also waiting in the wings.